By combining artificial intelligence with automated robotics and synthetic biology, researchers at the University of Illinois ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Antibiotic efflux pumps are expressed in all microbes, where they serve as crucial gatekeepers in resisting the cellular ...

A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

Based on several lines of interesting data, the authors conclude that FMRP, though associated with stalled ribosomes, does not determine the position on the mRNAs at which ribosomes stall. Although ...

The contribution of transcription, protein synthesis and degradation rates to the control of protein expression during differentiation was analyzed using quantitative proteomics and transcriptomics ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Department of Radiation Oncology and Molecular Radiation Sciences ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Department of Radiation Oncology and Molecular Radiation Sciences ...

Here we describe the total chemical synthesis of a 312-residue chaperone-dependent protein (DapA) in natural (l-) and mirror-image (d-) forms, the longest fully synthetic proteins yet reported. Using ...

Barcelona-based genetic medicines company SpliceBio has raised $135 million in a series B round to back its novel protein-splicing drug delivery system, the biotech announced Wednesday. The money will ...